Sat.Jul 29, 2023

article thumbnail

New tentative approval for Optimus Pharma drug obeticholic acid

Drug Patent Watch

Obeticholic acid is the generic ingredient in one branded drug marketed by Intercept Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Drug patent… The post New tentative approval for Optimus Pharma drug obeticholic acid appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New patent expiration for Takeda Pharms drug DEXILANT

Drug Patent Watch

Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from four suppliers. There are thirteen… The post New patent expiration for Takeda Pharms drug DEXILANT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB

Drug Patent Watch

Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are seven patents protecting this drug. Drug… The post New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Drug Patent Expirations for the Week of July 30, 2023

Drug Patent Watch

DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact… The post Drug Patent Expirations for the Week of July 30, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

New patent expiration for Bausch And drug BEPREVE

Drug Patent Watch

Annual Drug Patent Expirations for BEPREVE Bepreve is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from two suppliers. There are… The post New patent expiration for Bausch And drug BEPREVE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Which pharmaceutical companies have the most powder dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most powder dosed drugs… The post Which pharmaceutical companies have the most powder dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52